Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1033 of 1,261
  1. US 7538189

    Methods of making deuterated cyclosporin analogs

    Isotechnika, Inc. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  2. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  3. US 7537923

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  4. US 7537759

    Modulating angiogenesis

    The Regents of the University of California · Granted May 26, 2009 · Expires May 21, 2029

    granted
  5. US 7537421

    Dead spindle PTO with compliant grounding mechanism

    BLACK & DECKER INC. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  6. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted May 26, 2009 · Expires May 21, 2029

    granted
  7. US 7537791

    Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production

    INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted May 26, 2009 · Expires May 21, 2029

    granted
  8. US 7538108

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  9. US 7534887

    Thiazoline derivative and use of the same

    Takeda Pharmaceutical Company Limited · Granted May 19, 2009 · Expires May 14, 2029

    granted
  10. US 7534418

    Imaging agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 19, 2009 · Expires May 14, 2029

    granted
  11. US 7534775

    Methods and compositions for modulating cardiac contractility

    Sangamo Biosciences, Inc. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  12. US 7534565

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 19, 2009 · Expires May 14, 2029

    granted
  13. US 7534595

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  14. US 7534604

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  15. US 7534613

    Methods of treating parkinson's disease using viral vectors

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  16. US 7534761

    Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom

    Northwestern University · Granted May 19, 2009 · Expires May 14, 2029

    granted
  17. US 7534764

    Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  18. US 7534859

    Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  19. US 7534889

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  20. US 7534900

    Process for the purification of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  21. US 7534913

    Crystalline form of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  22. US 7534440

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  23. US 7534868

    Human antibodies to human delta like ligand 4

    REGENERON PHARMACEUTICALS, INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  24. EP 2057147

    PYRIMIDIN-DERIVATE

    ASTRAZENECA AB [SE] · Granted May 13, 2009 · Expires May 8, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.